Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer

Explore clinical trials studying Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer trial results

Completed

Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours

NCT01861496

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: The Phase One Unit, The Finsen Centre, Rigshospitalet Copenhagen, Denmark

Herlev & Gentofte Hospital Herlev, Denmark

Nordsjællands Hospital Hillerød Hillerød, Denmark

Vejle Sygehus Vejle, Denmark

View Trial Details

Genital Diseases (1)
Genital Diseases, Male (1)
Genital Neoplasms, Male (1)
Male Urogenital Diseases (1)
Neoplasms (1)
Neoplasms by Site (1)
Phase 1: Advanced or Refractory Solid Tumours (1)
Prostatic Diseases (1)

Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer

Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer trial results

Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours

Related conditions